These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Enzyme-linked immunoabsorbent assays in the detection of Chlamydia trachomatis: how valid are they?
    Author: Weismeier E, Bruckner DA, Malotte CK, Manduke L.
    Journal: Diagn Microbiol Infect Dis; 1988 Apr; 9(4):219-23. PubMed ID: 3180707.
    Abstract:
    Two enzyme-linked immunoabsorbent assays (Chlamydiazyme, Abbott Laboratories, North Chicago, IL, and IDEIA, Boots-CellTech Diagnostics Inc., East Hanover, NJ) specific for the detection of Chlamydia trachomatis antigen were used to assess 451 cervical specimens. All specimens obtained from the subjects were also simultaneously cultured for Chlamydia. Both assays identified 90.9% (20/22) of the culture positive cases. Chlamydiazyme identified two and IDEIA three additional specimens as positive. Of these additional positive tests, one of two Chlamydiazyme and three of three IDEIA specimens were confirmed as positive by the direct fluorescent antibody technique (MicroTrak, Syva Co., Palo Alto, CA). Given the inexpense, availability, ease of performance, high sensitivity (91%), and specificity (99%) of these tests, both should become valuable tools to objectively assess women at risk for this common sexually transmitted disease.
    [Abstract] [Full Text] [Related] [New Search]